Xiangxiang Wu

Anhui University of Science and Technology

Also affiliated with Anhui Science and Technology University, First Affiliated Hospital of Henan University

Materials ScienceMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The STEAP4 target NQO1 mediates colon tumorigenesis”.

The STEAP4 target NQO1 mediates colon tumorigenesis

Journal of Cell Science(2025)10.1242/jcs.263402

N/A

0DataRank · unranked

4 citations

Luke Villareal, Xiangxiang Wu, Mariella Arcos, Jordan Lee, David Martin +5 more

The novel curcumin analogue AKT-100 targets both mutant p53 and STAT3 in gynecologic cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.06.680794

N/A

0DataRank · unranked

1 citations

Lane E. Smith, Jamie L. Padilla, Alexander Goss, Daisy Belmares-Ortega, Xiangxiang Wu +7 more

The potential for p53 reactivators to increase the sensitivity of aggressive gynecologic cancers to immunotherapy 3272

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1090

N/A

0DataRank · unranked

0 citations

Jamie L. Padilla, Geneva L. Williams, Daisy Belmares-Ortega, Xiangxiang Wu, Eric Bartee +2 more